We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

18 hedge funds and large institutions have $1.19M invested in Bio-Path Holdings Inc in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

40% more capital invested

Capital invested by funds: $847K → $1.19M (+$338K)

29% more funds holding

Funds holding: 14 → 18 (+4)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$168K
2
VF
Virtu Financial
New York
+$125K
3
Goldman Sachs
Goldman Sachs
New York
+$63K
4
Renaissance Technologies
Renaissance Technologies
New York
+$61.8K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$50.8K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6.68K
2
Morgan Stanley
Morgan Stanley
New York
-$600

BPTH Hedge Fund Activity: Q4 2020 in Review

18 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2020, worth a combined $1.19M — up 40% from $847K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BPTH positions and 0 closed out — a net gain of 4 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $168K. The largest seller was UBS Group, cutting an estimated $6.68K.

  • 18 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2020, up from 14 in Q3 2020.
  • Funds reported $1.19M of Bio-Path Holdings Inc stock for Q4 2020, up 40% quarter-over-quarter.
  • 4 funds opened new Bio-Path Holdings Inc positions in Q4 2020 and 0 closed out, a net change of +4 holders.
  • The largest Bio-Path Holdings Inc buyer in Q4 2020 was Vanguard Group, an estimated $168K added.
  • The largest Bio-Path Holdings Inc seller in Q4 2020 was UBS Group, an estimated $6.68K sold.

Based on aggregated 13F filings for Q4 2020.